These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 8392550)
1. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
2. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. Drapeau G; deBlois D; Marceau F J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280 [TBL] [Abstract][Full Text] [Related]
3. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. Vianna RM; Calixto JB Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide. Audet R; Rioux F; Drapeau G; Marceau F J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175 [TBL] [Abstract][Full Text] [Related]
6. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Butt SK; Dawson LG; Hall JM Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687 [TBL] [Abstract][Full Text] [Related]
7. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors. MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157 [TBL] [Abstract][Full Text] [Related]
8. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764 [TBL] [Abstract][Full Text] [Related]
9. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513 [TBL] [Abstract][Full Text] [Related]
10. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury. Larrivée JF; Bachvarov DR; Houle F; Landry J; Huot J; Marceau F J Immunol; 1998 Feb; 160(3):1419-26. PubMed ID: 9570562 [TBL] [Abstract][Full Text] [Related]
11. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor. Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET J Pharmacol Exp Ther; 1996 Jun; 277(3):1337-43. PubMed ID: 8667195 [TBL] [Abstract][Full Text] [Related]
12. Bradykinin-induced burst of prostaglandin formation in osteoblasts is mediated via B2 bradykinin receptors. Ljunggren O; Vavrek R; Stewart JM; Lerner UH J Bone Miner Res; 1991 Aug; 6(8):807-15. PubMed ID: 1664644 [TBL] [Abstract][Full Text] [Related]
13. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells. Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism. Gera L; Fortin JP; Adam A; Stewart JM; Marceau F J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig. Gobeil F; Filteau C; Pheng LH; Jukic D; Nguyen-Le XK; Regoli D Can J Physiol Pharmacol; 1996 Feb; 74(2):137-44. PubMed ID: 8723025 [TBL] [Abstract][Full Text] [Related]
16. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG). Campos MM; Henriques MG; Calixto JB Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756 [TBL] [Abstract][Full Text] [Related]
17. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648 [TBL] [Abstract][Full Text] [Related]
18. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of [3H]-des-Arg10-kallidin binding to the bradykinin B1 receptor by interleukin-1 beta in isolated smooth muscle cells: correlation with B1 agonist-induced PGI2 production. Galizzi JP; Bodinier MC; Chapelain B; Ly SM; Coussy L; Giraud S; Neliat G; Jean T Br J Pharmacol; 1994 Oct; 113(2):389-94. PubMed ID: 7834189 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors. Campos AH; Calixto JB J Pharmacol Exp Ther; 1994 Feb; 268(2):902-9. PubMed ID: 8114004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]